XML 32 R12.htm IDEA: XBRL DOCUMENT
v3.19.2

Intangible Assets | 9 Months Ended
--- | ---
Jul. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract] |
Intangible Assets | Intangible Assets Goodwill
(In millions) | CooperVision |  | CooperSurgical |  | Total
Balance at October 31, 2017 | $ | 1,735.7 |  |  | $ | 619.1 |  |  | $ | 2,354.8 |
Net additions during the year ended October 31, 2018 | 36.8 |  |  | 34.4 |  |  | 71.2 |
Translation | (29.6 | ) |  | (4.3 | ) |  | (33.9 | )
Balance at October 31, 2018 | 1,742.9 |  |  | 649.2 |  |  | 2,392.1 |
Net additions during the nine months ended July 31, 2019 | 13.8 |  |  | 22.0 |  |  | 35.8 |
Translation | (33.0 | ) |  | (3.5 | ) |  | (36.5 | )
Balance at July 31, 2019 | $ | 1,723.7 |  |  | $ | 667.7 |  |  | $ | 2,391.4 |
Effective April 30, 2019, there was a change in the reporting units as a result of realignment in the internal reporting structure of the business around markets and customers at CooperSurgical. As such, Cooper Surgical has evolved into two reporting units, namely, Office/Surgical and Fertility, which reflects management oversight of operations. The change in reporting units did not result in a change in operating segments. We allocated CooperSurgical's goodwill based on relative fair values utilizing the discounted cash flow method and guideline public company method as our allocation base, and the allocated fair values exceeded the carrying values for each of the three reporting units as of April 30, 2019. We evaluate goodwill for impairment annually during the fiscal third quarter and when an event occurs or circumstances change such that it is reasonably possible that impairment may exist. We account for goodwill and evaluate our goodwill balances and test them for impairment in accordance with related accounting standards. We performed our annual impairment assessment in our third quarter of fiscal 2019 and 2018, and our analysis indicated that we had no impairment of goodwill in our reporting units. We performed a qualitative assessment to test each reporting unit's goodwill for impairment. Qualitative factors considered in this assessment include industry and market considerations, overall financial performance and other relevant events and factors affecting each reporting unit. Based on our qualitative assessment, if we determine that the fair value of a reporting unit is more likely than not to be less than its carrying amount, the fair value of a reporting unit will be compared with its carrying amount and an impairment charge will be recognized for the amount that the carrying value exceeds the fair value of the reporting unit. A reporting unit is the level of reporting at which goodwill is tested for impairment. Our reporting units are CooperVision, Office/Surgical and Fertility reflecting the current way we manage our business. Goodwill impairment analysis and measurement is a process that requires significant judgment. If our common stock price trades below book value per share, there are changes in market conditions or a future downturn in our business, or a future goodwill impairment test indicates an impairment of our goodwill, we may have to recognize a non-cash impairment of goodwill that could be material and could adversely affect our results of operations in the period recognized and also adversely affect our total assets and stockholders' equity. Other Intangible Assets
| July 31, 2019 |  | October 31, 2018 |  |
(In millions) | Gross Carrying Amount |  | Accumulated Amortization |  | Gross Carrying Amount |  | Accumulated Amortization |  | Weighted Average Amortization Period (In years)
Intangible assets with definite lives: |  |  |  |  |  |  |  |  |
Trademarks | $ | 148.3 |  |  | $ | 24.6 |  |  | $ | 138.1 |  |  | $ | 16.9 |  |  | 14
Composite intangible asset | 1,061.9 |  |  | 123.9 |  |  | 1,061.9 |  |  | 70.8 |  |  | 15
Technology | 398.8 |  |  | 213.0 |  |  | 387.2 |  |  | 190.7 |  |  | 11
Customer relationships | 356.1 |  |  | 187.0 |  |  | 350.0 |  |  | 168.6 |  |  | 13
License and distribution rights and other (1) | 27.8 |  |  | 14.7 |  |  | 74.9 |  |  | 52.7 |  |  | 11
| 1,992.9 |  |  | $ | 563.2 |  |  | 2,012.1 |  |  | $ | 499.7 |  |  | 14
Less: accumulated amortization and translation | 563.2 |  |  |  |  | 499.7 |  |  |  |  |
Intangible assets with definite lives, net | 1,429.7 |  |  |  |  | 1,512.4 |  |  |  |  |
Intangible assets with indefinite lives, net (2) | 8.9 |  |  |  |  | 8.9 |  |  |  |  |
Total other intangible assets, net | $ | 1,438.6 |  |  |  |  | $ | 1,521.3 |  |  |  |  |
(1) In the second quarter of fiscal 2019, CooperSurgical sold an exclusive distribution right to distribute Filshie Clip System in the U.S. for $21.0 million and recognized a gain of $19.0 million. In the third quarter of fiscal 2019, CooperVision removed $37.3 million of fully amortized non-compete agreements. (2) Intangible assets with indefinite lives include trademark and technology intangible assets. Balances include foreign currency translation adjustments. As of July 31, 2019, the estimation of amortization expenses for intangible assets with definite lives is as follows:
Fiscal years: | (In millions)
Remainder of 2019 | $ | 35.1 |
2020 | 135.6 |
2021 | 134.3 |
2022 | 132.4 |
2023 | 130.2 |
Thereafter | 862.1 |
Total remaining amortization for intangible assets with definite lives | $ | 1,429.7 |
The Company assesses definite-lived intangible assets whenever events or changes in circumstances indicate that the carrying amount of a definite-lived intangible asset (asset group) may not be recoverable. When events or changes in circumstances indicate that the carrying amount of a definite-lived intangible asset may not be recoverable, the Company evaluates whether the definite-lived intangible asset is impaired by comparing its carrying value to its undiscounted future cash flows. The Company assesses indefinite-lived intangible assets annually in the third quarter of the fiscal year, or whenever events or circumstances indicate that the carrying amount of an indefinite-lived intangible asset (asset group) may not be recoverable. The Company evaluates whether the indefinite-lived intangible asset is impaired by comparing its carrying value to its fair value. If the carrying value of a definite-lived or indefinite-lived intangible asset is not recoverable, an impairment loss is recognized based on the amount by which the carrying value exceeds the fair value. The inputs used in the fair value analysis fall within Level 3 of the fair value hierarchy due to the use of significant unobservable inputs to determine fair value. The Company did not recognize any material definite-lived or indefinite-lived intangible asset impairment charges during the three and nine months ended July 31, 2019.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -URI http://asc.fasb.org/topic&trid=2144416 + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration